You just read:

Intarcia and Calibr Announce Collaboration and In-Licensing Deal Aimed at Delivering a Next Generation Combination Product for Diabetes and Obesity

News provided by

Intarcia Therapeutics, Inc.

Jan 09, 2017, 09:00 ET